 ARLINGTON, Mass., Sept. 06, 2022 GLOBE NEWSWIRE -- Kala Pharmaceuticals, Inc. NASDAQ:KALA, a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare diseases of the eye, today announced that it will present at the H.C. Wainwright 24th Annual Global Investment Conference, being held virtually and in New York, NY. A pre-recorded fireside chat will be made available beginning Monday, September 12, 2022 at 7:00 a.m. ET. Management will also be available for one-on-one meetings throughout the conference. 